|
Global travel is commonplace, as people of all ages travel more often and to more varied locations. Often, today's travel destinations and popular local activities can put visitors at risk of infectious diseases, including VPH. Although many infections with HAV and/or HBV result from travel, people often depart to endemic areas without recommended immunizations. Safe and effective vaccines are widely available for immunization against hepatitis A and B, the most common vaccine-preventable diseases in travelers, including a combination vaccine to prevent both HAV and HBV. It is important that infectious disease specialists, gastroenterologists, travel medicine specialists, and other physicians who manage patients who travel stay apprised of up-to-date trends and recommendations regarding prevention of VPH in travelers. In particular, clinicians need to be cognizant of VPH prevention in special traveler populations such as the elderly, pregnant women, immunocompromised persons, and last-minute travelers. This educational monograph provides an overview of recent trends in the epidemiology and risks of VPH, current recommendations for immunization, conventional and accelerated schedules, and VPH prophylaxis in special populations.
The purpose of this activity is to enhance clinician knowledge and competence in immunization against vaccine-preventable hepatitis (VPH) in travelers to decrease the incidence of acute and chronic hepatitis A virus (HAV) and hepatitis B virus (HBV) infections and their complications.
Specialty Options:
Sponsored by Discovery Institute of Medical Education (DIME).
This activity is funded through an educational grant from GlaxoSmithKline.
[Back to top]
|
